Quick Answer
Trulicity (dulaglutide) is FDA-approved for type 2 diabetes, not weight loss. However, it is sometimes prescribed off-label for weight management. Trulicity is a GLP-1 receptor agonist, similar to Ozempic, but research shows it typically causes less weight loss than semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound).
If weight loss is your primary goal, other GLP-1 medications may be more effective. Talk to your doctor about the best option for your situation.
Key Points
- Trulicity is FDA-approved for type 2 diabetes, not weight loss
- Weight loss with Trulicity is typically 5-10 pounds over 6 months
- Ozempic and Mounjaro cause more weight loss in studies
- Trulicity may be preferred for some people due to convenience or side effects
- Once-weekly injection, available in single-use pen
Products for Trulicity users:
- Smart scale - track weight changes
- Blood glucose monitor - monitor blood sugar
What Is Trulicity?
Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist. It was approved by the FDA in 2014 for type 2 diabetes.
Key facts:
- Generic name: dulaglutide
- Drug class: GLP-1 receptor agonist
- FDA-approved for: Type 2 diabetes
- Form: Single-use pre-filled pen
- Dosing: Once weekly
Trulicity works by:
- Stimulating insulin release when blood sugar is high
- Reducing glucose production by the liver
- Slowing stomach emptying
- Reducing appetite (less than some other GLP-1s)
Trulicity for Weight Loss: What the Research Shows
AWARD Studies (Diabetes Trials)
The main Trulicity trials focused on diabetes, but tracked weight as a secondary outcome.
Results:
- Trulicity 1.5 mg: Average weight loss of 2-5 pounds over 6 months
- Trulicity 3.0 mg and 4.5 mg: Average weight loss of 5-10 pounds over 6 months
Higher doses showed more weight loss but were not initially approved. The 3.0 mg and 4.5 mg doses were approved in 2020.
Comparison to Other GLP-1s
| Medication | Average Weight Loss | Study Duration |
|---|---|---|
| Trulicity 4.5 mg | 5-10 pounds | 6 months |
| Ozempic 1 mg | 10-15 pounds | 6 months |
| Wegovy 2.4 mg | 15-20% of body weight | 68 weeks |
| Mounjaro (tirzepatide) | 15-20% of body weight | 72 weeks |
Trulicity causes less weight loss than semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro). This is consistent across multiple studies.
Why Trulicity May Cause Less Weight Loss
- Dulaglutide has a different molecular structure than semaglutide
- It may not affect appetite centers as strongly
- The approved doses are lower relative to other GLP-1s
Trulicity Dosing
Trulicity comes in a single-use pre-filled pen. There is no need to attach needles or prime.
Available Doses
- 0.75 mg weekly (starting dose)
- 1.5 mg weekly (common maintenance)
- 3.0 mg weekly (higher dose)
- 4.5 mg weekly (highest approved)
How Dosing Works
- Start at 0.75 mg weekly for 4 weeks
- Increase to 1.5 mg weekly
- May increase to 3.0 mg or 4.5 mg if needed for blood sugar control
For weight loss, doctors sometimes start at 1.5 mg or increase more quickly, but this is off-label.
Side Effects
Trulicity has similar side effects to other GLP-1 medications:
Common Side Effects
- Nausea (most common)
- Diarrhea
- Vomiting
- Abdominal pain
- Decreased appetite
- Fatigue
Side effects are usually worst in the first few weeks and improve over time.
Less Common but Serious
- Pancreatitis
- Gallbladder disease
- Kidney problems
- Thyroid tumors (seen in animal studies, human risk unclear)
- Hypoglycemia (when combined with certain diabetes medications)
Trulicity vs. Other GLP-1s
Trulicity vs. Ozempic
| Factor | Trulicity | Ozempic |
|---|---|---|
| Active Drug | Dulaglutide | Semaglutide |
| Weight Loss | 5-10 pounds | 10-15 pounds |
| Device | Single-use pen | Reusable pen or pre-filled |
| Dosing | Weekly | Weekly |
| FDA Approval | Diabetes only | Diabetes (weight loss off-label) |
Ozempic typically causes more weight loss. However, some people prefer Trulicity because:
- The pen is easier to use (no needle attachment)
- Side effects may be milder for some people
- Insurance coverage may differ
Trulicity vs. Mounjaro
Mounjaro (tirzepatide) is a newer medication that targets both GLP-1 and GIP receptors. It causes significantly more weight loss than Trulicity.
In head-to-head studies, tirzepatide outperformed dulaglutide for both blood sugar and weight.
Trulicity vs. Wegovy
Wegovy is FDA-approved for weight loss and contains high-dose semaglutide. If weight loss is your primary goal, Wegovy is more effective than Trulicity.
Who Might Choose Trulicity?
Trulicity might be right for you if:
- You have type 2 diabetes and want once-weekly dosing
- You prefer a simple, single-use pen (no needle handling)
- You cannot tolerate other GLP-1 medications
- Your insurance covers Trulicity but not other options
- Your doctor recommends it for your specific situation
Trulicity may not be ideal if:
- Weight loss is your primary goal (other options are more effective)
- You want maximum appetite suppression
- You have severe stomach problems
- You are looking for the lowest-cost option
Cost of Trulicity
Without Insurance
- Approximately $800-900 per month
- Prices vary by pharmacy
With Insurance
- Coverage depends on your plan
- Diabetes patients often have better coverage
- Weight loss use may not be covered
Savings Options
- Manufacturer coupon available
- Patient assistance programs for those who qualify
How to Get Trulicity
For Type 2 Diabetes
- Prescription from your doctor
- Most insurance plans cover it
- Standard prior authorization may apply
For Weight Loss (Off-Label)
- Doctor must agree it is appropriate
- Insurance may not cover off-label use
- You may pay out-of-pocket
If weight loss is your goal, discuss all GLP-1 options with your doctor. They can help you choose based on effectiveness, cost, and your health history.
Questions to Ask Your Doctor
- Is Trulicity the best GLP-1 option for my goals?
- How does Trulicity compare to Ozempic or Mounjaro for me?
- Will my insurance cover Trulicity?
- What dose should I start with?
- How will we track progress?
- What side effects should I watch for?
The Bottom Line
Trulicity can cause some weight loss, but it is less effective than Ozempic, Wegovy, or Mounjaro for this purpose. It is FDA-approved for type 2 diabetes.
If you have diabetes and want a simple once-weekly injection, Trulicity may be a good choice. If weight loss is your main goal, talk to your doctor about other GLP-1 options.
Key takeaways:
- Trulicity is FDA-approved for diabetes, not weight loss
- Weight loss is typically 5-10 pounds over 6 months
- Other GLP-1s cause more weight loss
- The single-use pen is convenient
- Insurance coverage varies
Work with your doctor to find the right medication for your needs.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.